Related Experiment Videos

Epstein-Barr virus suppresses a G(2)/M checkpoint activated by genotoxins

M Wade1, M J Allday

  • 1Section of Virology and Cell Biology and Ludwig Institute for Cancer Research, Imperial College of Science Technology and Medicine, London W2 1PG, United Kingdom.

Insights

Epstein-Barr virus (EBV) infection protects p53-null Burkitt lymphoma cells from genotoxic drugs by inactivating the G(2)/M cell cycle checkpoint, not by blocking apoptosis directly.

Area of Science:

  • Virology
  • Cell Biology
  • Cancer Research

Background:

  • Epstein-Barr virus (EBV)-negative Burkitt lymphoma cell lines lacking functional p53 are sensitive to genotoxic drugs.
  • These cells undergo apoptosis and cell cycle arrest at G(2)/M.
  • Latent EBV infection confers resistance to genotoxic agents in these cells.

Purpose of the Study:

  • To investigate how latent EBV infection protects genotoxin-sensitive Burkitt lymphoma cells from apoptosis and cell cycle arrest.
  • To determine the role of EBV latent genes, particularly LMP-1, in this protective mechanism.
  • To elucidate the impact of EBV on cell cycle checkpoints and genomic integrity.

Main Methods:

  • Genotoxic drug treatment of EBV-negative and latently EBV-infected Burkitt lymphoma cell lines (BL41, Ramos).
  • 5-bromo-2'-deoxyuridine labeling to assess cell cycle progression.
  • Analysis of cells infected with a mutant EBV (P3HR1) lacking certain latent genes.
  • Stable expression of EBV's LMP-1 protein in BL41 cells.
  • Western blot analysis of Bcl-2 family proteins.

Main Results:

  • Latent EBV infection protects p53-null Burkitt lymphoma cells from genotoxic drug-induced apoptosis and G(2)/M arrest.
  • EBV abrogates the G(2)/M checkpoint activation or signaling, rather than blocking apoptosis directly.
  • The primary antiapoptotic EBV latent protein, LMP-1, is not responsible for this protection.
  • Bcl-2 family protein levels did not correlate with the protective outcome.

Conclusions:

  • A subset of EBV latent gene products inactivates the G(2)/M cell cycle checkpoint, preserving genomic integrity.
  • This mechanism is likely crucial for EBV-driven B cell transformation and tumorigenesis.
  • EBV serves as a valuable tool for studying cell cycle regulation and apoptosis interplay.

Related Concept Videos